ANALOG DEVICES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ANALOG DEVICES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Nov 3, 2018 | $1.60B | Nov 27, 2018 |
| FY2018 | Aug 4, 2018 | $1.57B | Nov 27, 2018 |
| FY2018 | May 5, 2018 | $1.51B | Nov 27, 2018 |
| FY2018 | Feb 3, 2018 | $1.52B | Nov 27, 2018 |
| FY2018 | Oct 28, 2017 | $1.54B | Nov 27, 2018 |
| FY2018 | Jul 29, 2017 | $1.43B | Nov 27, 2018 |
| FY2018 | Apr 29, 2017 | $1.15B | Nov 27, 2018 |
| FY2018 | Jan 28, 2017 | $984.45M | Nov 27, 2018 |
| FY2018 | Oct 29, 2016 | $3.42B | Nov 27, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $11.02B | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | $9.43B | Nov 25, 2025 |
| FY2025 | Oct 28, 2023 | $12.31B | Nov 25, 2025 |
| FY2024 | Oct 29, 2022 | $12.01B | Nov 26, 2024 |
| FY2023 | Oct 30, 2021 | $7.32B | Nov 21, 2023 |
| FY2022 | Oct 31, 2020 | $5.60B | Nov 22, 2022 |
| FY2019 | Nov 2, 2019 | $1.44B | Nov 26, 2019 |
| FY2019 | Aug 3, 2019 | $1.48B | Nov 26, 2019 |
| FY2019 | May 4, 2019 | $1.53B | Nov 26, 2019 |
| FY2019 | Feb 2, 2019 | $1.54B | Nov 26, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Oct 28, 2017 | $1.54B | Nov 22, 2017 |
| FY2017 | Jul 29, 2017 | $1.43B | Nov 22, 2017 |
| FY2017 | Apr 29, 2017 | $1.15B | Nov 22, 2017 |
| FY2017 | Jan 28, 2017 | $984.45M | Nov 22, 2017 |
| FY2016 | Oct 29, 2016 | $1.00B | Nov 22, 2016 |
| FY2016 | Jul 30, 2016 | $869.59M | Nov 22, 2016 |
| FY2016 | Apr 30, 2016 | $778.77M | Nov 22, 2016 |
| FY2016 | Jan 30, 2016 | $769.43M | Nov 22, 2016 |
| FY2015 | Oct 31, 2015 | $978.72M | Nov 24, 2015 |
| FY2015 | Aug 1, 2015 | $863.37M | Nov 24, 2015 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $6.77B | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | $5.38B | Nov 25, 2025 |
| FY2025 | Oct 28, 2023 | $7.88B | Nov 25, 2025 |
| FY2024 | Oct 29, 2022 | $7.53B | Nov 26, 2024 |
| FY2023 | Oct 30, 2021 | $4.53B | Nov 21, 2023 |
| FY2022 | Oct 31, 2020 | $3.69B | Nov 22, 2022 |
| FY2019 | Nov 2, 2019 | $942.19M | Nov 26, 2019 |
| FY2019 | Aug 3, 2019 | $997.81M | Nov 26, 2019 |
| FY2019 | May 4, 2019 | $1.03B | Nov 26, 2019 |
| FY2019 | Feb 2, 2019 | $1.04B | Nov 26, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $2.27B | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | $1.64B | Nov 25, 2025 |
| FY2025 | Oct 28, 2023 | $3.31B | Nov 25, 2025 |
| FY2024 | Oct 29, 2022 | $2.75B | Nov 26, 2024 |
| FY2023 | Oct 30, 2021 | $1.39B | Nov 21, 2023 |
| FY2022 | Oct 31, 2020 | $1.22B | Nov 22, 2022 |
| FY2021 | Nov 2, 2019 | $1.36B | Dec 3, 2021 |
| FY2020 | Nov 3, 2018 | $1.51B | Nov 24, 2020 |
| FY2019 | Oct 28, 2017 | $805.38M | Nov 26, 2019 |
| FY2018 | Oct 29, 2016 | $861.66M | Nov 27, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $2.93B | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | $2.03B | Nov 25, 2025 |
| FY2025 | Oct 28, 2023 | $3.82B | Nov 25, 2025 |
| FY2024 | Oct 29, 2022 | $3.28B | Nov 26, 2024 |
| FY2023 | Oct 30, 2021 | $1.69B | Nov 21, 2023 |
| FY2022 | Oct 31, 2020 | $1.50B | Nov 22, 2022 |
| FY2019 | Nov 2, 2019 | $338.36M | Nov 26, 2019 |
| FY2019 | Aug 3, 2019 | $446.73M | Nov 26, 2019 |
| FY2019 | May 4, 2019 | $469.70M | Nov 26, 2019 |
| FY2019 | Feb 2, 2019 | $455.83M | Nov 26, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $1.77B | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | $1.49B | Nov 25, 2025 |
| FY2025 | Oct 28, 2023 | $1.66B | Nov 25, 2025 |
| FY2024 | Oct 29, 2022 | $1.70B | Nov 26, 2024 |
| FY2023 | Oct 30, 2021 | $1.30B | Nov 21, 2023 |
| FY2022 | Oct 31, 2020 | $1.05B | Nov 22, 2022 |
| FY2019 | Nov 2, 2019 | $277.02M | Nov 26, 2019 |
| FY2019 | Aug 3, 2019 | $280.10M | Nov 26, 2019 |
| FY2019 | May 4, 2019 | $285.85M | Nov 26, 2019 |
| FY2019 | Feb 2, 2019 | $287.38M | Nov 26, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $1.26B | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | $1.07B | Nov 25, 2025 |
| FY2025 | Oct 28, 2023 | $1.27B | Nov 25, 2025 |
| FY2024 | Oct 29, 2022 | $1.27B | Nov 26, 2024 |
| FY2023 | Oct 30, 2021 | $915.42M | Nov 21, 2023 |
| FY2022 | Oct 31, 2020 | $659.92M | Nov 22, 2022 |
| FY2019 | Nov 2, 2019 | $154.80M | Nov 26, 2019 |
| FY2019 | Aug 3, 2019 | $162.83M | Nov 26, 2019 |
| FY2019 | May 4, 2019 | $163.13M | Nov 26, 2019 |
| FY2019 | Feb 2, 2019 | $167.34M | Nov 26, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $4.81B | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | $3.85B | Nov 25, 2025 |
| FY2025 | Oct 28, 2023 | $4.82B | Nov 25, 2025 |
| FY2024 | Oct 29, 2022 | $4.48B | Nov 26, 2024 |
| FY2023 | Oct 30, 2021 | $2.74B | Nov 21, 2023 |
| FY2022 | Oct 31, 2020 | $2.01B | Nov 22, 2022 |
| FY2021 | Nov 2, 2019 | $2.25B | Dec 3, 2021 |
| FY2020 | Nov 3, 2018 | $2.44B | Nov 24, 2020 |
| FY2019 | Oct 28, 2017 | $1.15B | Nov 26, 2019 |
| FY2018 | Oct 29, 2016 | $1.29B | Nov 27, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $533.55M | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | $730.46M | Nov 25, 2025 |
| FY2025 | Oct 28, 2023 | $1.26B | Nov 25, 2025 |
| FY2024 | Oct 29, 2022 | $699.31M | Nov 26, 2024 |
| FY2023 | Oct 30, 2021 | $343.68M | Nov 21, 2023 |
| FY2022 | Oct 31, 2020 | $165.69M | Nov 22, 2022 |
| FY2021 | Nov 2, 2019 | $275.37M | Dec 3, 2021 |
| FY2020 | Nov 3, 2018 | $254.88M | Nov 24, 2020 |
| FY2019 | Oct 28, 2017 | $204.10M | Nov 26, 2019 |
| FY2018 | Oct 29, 2016 | $127.40M | Nov 27, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $47.99B | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | $48.23B | Nov 25, 2025 |
| FY2024 | Oct 28, 2023 | $48.79B | Nov 26, 2024 |
| FY2023 | Oct 29, 2022 | $50.30B | Nov 21, 2023 |
| FY2022 | Oct 30, 2021 | $52.32B | Nov 22, 2022 |
| FY2021 | Oct 31, 2020 | $21.47B | Dec 3, 2021 |
| FY2020 | Nov 2, 2019 | $21.39B | Nov 24, 2020 |
| FY2019 | Nov 3, 2018 | $20.44B | Nov 26, 2019 |
| FY2018 | Oct 28, 2017 | $21.14B | Nov 27, 2018 |
| FY2017 | Oct 29, 2016 | $7.97B | Nov 22, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $33.82B | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | $35.18B | Nov 25, 2025 |
| FY2024 | Oct 28, 2023 | $35.57B | Nov 26, 2024 |
| FY2023 | Oct 29, 2022 | $36.47B | Nov 21, 2023 |
| FY2022 | Oct 30, 2021 | $37.99B | Nov 22, 2022 |
| FY2021 | Oct 31, 2020 | $12.00B | Dec 3, 2021 |
| FY2020 | Nov 2, 2019 | $11.71B | Nov 24, 2020 |
| FY2019 | Nov 3, 2018 | $11.27B | Nov 26, 2019 |
| FY2018 | Oct 28, 2017 | $10.16B | Nov 27, 2018 |
| FY2017 | Oct 29, 2016 | $5.17B | Nov 22, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $26.95B | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | $26.91B | Nov 25, 2025 |
| FY2025 | Oct 28, 2023 | $26.91B | Nov 25, 2025 |
| FY2023 | Oct 29, 2022 | $26.91B | Nov 21, 2023 |
| FY2023 | Oct 30, 2021 | $26.92B | Nov 21, 2023 |
| FY2022 | Oct 31, 2020 | $12.28B | Nov 22, 2022 |
| FY2021 | Nov 2, 2019 | $12.26B | Dec 3, 2021 |
| FY2020 | Nov 3, 2018 | $12.25B | Nov 24, 2020 |
| FY2019 | Oct 28, 2017 | $12.22B | Nov 26, 2019 |
| FY2018 | Oct 29, 2016 | $1.68B | Nov 27, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $10.54B | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | $10.20B | Nov 25, 2025 |
| FY2024 | Oct 28, 2023 | $10.36B | Nov 26, 2024 |
| FY2023 | Oct 29, 2022 | $8.72B | Nov 21, 2023 |
| FY2022 | Oct 30, 2021 | $7.52B | Nov 22, 2022 |
| FY2021 | Oct 31, 2020 | $7.24B | Dec 3, 2021 |
| FY2020 | Nov 2, 2019 | $6.90B | Nov 24, 2020 |
| FY2020 | Nov 4, 2018 | $6.31B | Nov 24, 2020 |
| FY2021 | Nov 3, 2018 | $5.98B | Dec 3, 2021 |
| FY2018 | Oct 28, 2017 | $4.91B | Nov 27, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $2.50B | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | $1.99B | Nov 25, 2025 |
| FY2024 | Oct 28, 2023 | $958.06M | Nov 26, 2024 |
| FY2023 | Oct 29, 2022 | $1.47B | Nov 21, 2023 |
| FY2022 | Oct 30, 2021 | $1.98B | Nov 22, 2022 |
| FY2021 | Oct 31, 2020 | $1.06B | Dec 3, 2021 |
| FY2020 | Nov 2, 2019 | $648.32M | Nov 24, 2020 |
| FY2019 | Nov 3, 2018 | $816.59M | Nov 26, 2019 |
| FY2018 | Oct 28, 2017 | $1.05B | Nov 27, 2018 |
| FY2018 | Oct 29, 2016 | $921.13M | Nov 27, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | 4 | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | 3 | Nov 25, 2025 |
| FY2025 | Oct 28, 2023 | 6 | Nov 25, 2025 |
| FY2024 | Oct 29, 2022 | 5 | Nov 26, 2024 |
| FY2023 | Oct 30, 2021 | 3 | Nov 21, 2023 |
| FY2022 | Oct 31, 2020 | 3 | Nov 22, 2022 |
| FY2019 | Nov 2, 2019 | 0 | Nov 26, 2019 |
| FY2019 | Aug 3, 2019 | 0 | Nov 26, 2019 |
| FY2019 | May 4, 2019 | 0 | Nov 26, 2019 |
| FY2019 | Feb 2, 2019 | 0 | Nov 26, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | 4 | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | 3 | Nov 25, 2025 |
| FY2025 | Oct 28, 2023 | 6 | Nov 25, 2025 |
| FY2024 | Oct 29, 2022 | 5 | Nov 26, 2024 |
| FY2023 | Oct 30, 2021 | 3 | Nov 21, 2023 |
| FY2022 | Oct 31, 2020 | 3 | Nov 22, 2022 |
| FY2019 | Nov 2, 2019 | 0 | Nov 26, 2019 |
| FY2019 | Aug 3, 2019 | 0 | Nov 26, 2019 |
| FY2019 | May 4, 2019 | 0 | Nov 26, 2019 |
| FY2019 | Feb 2, 2019 | 0 | Nov 26, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | 489.65M | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | 496.30M | Nov 25, 2025 |
| FY2024 | Oct 28, 2023 | 496.26M | Nov 26, 2024 |
| FY2023 | Oct 29, 2022 | 509.30M | Nov 21, 2023 |
| FY2022 | Oct 30, 2021 | 525.33M | Nov 22, 2022 |
| FY2021 | Oct 31, 2020 | 369.48M | Dec 3, 2021 |
| FY2020 | Nov 2, 2019 | 368.30M | Nov 24, 2020 |
| FY2019 | Nov 3, 2018 | 370.16M | Nov 26, 2019 |
| FY2017 | Oct 28, 2017 | 368.64M | Nov 22, 2017 |
| FY2018 | Oct 29, 2016 | 368.64M | Nov 27, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 1, 2025 | $1.92B | Nov 25, 2025 |
| FY2025 | Nov 2, 2024 | $1.80B | Nov 25, 2025 |
| FY2025 | Oct 28, 2023 | $1.68B | Nov 25, 2025 |
| FY2024 | Oct 29, 2022 | $1.54B | Nov 26, 2024 |
| FY2023 | Oct 30, 2021 | $1.11B | Nov 21, 2023 |
| FY2022 | Oct 31, 2020 | $886.16M | Nov 22, 2022 |
| FY2021 | Nov 2, 2019 | $777.48M | Dec 3, 2021 |
| FY2020 | Nov 3, 2018 | $703.31M | Nov 24, 2020 |
| FY2019 | Oct 28, 2017 | $602.12M | Nov 26, 2019 |
| FY2018 | Oct 29, 2016 | $513.18M | Nov 27, 2018 |